These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30467244)

  • 81. TP53 codon 72 polymorphism in pigmentary phenotypes.
    Costa KA; Guillo LA
    J Biosci; 2012 Mar; 37(1):33-9. PubMed ID: 22357201
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Recurrence risk evaluation in T1N1M0/T2N0M0/T3N0M0 gastric cancer with TP53 codon 72 polymorphisms.
    Ohmori Y; Nomura T; Fukushima N; Takahashi F; Iwaya T; Koeda K; Nishizuka SS;
    J Surg Oncol; 2019 Dec; 120(7):1154-1161. PubMed ID: 31578743
    [TBL] [Abstract][Full Text] [Related]  

  • 83. TP53 codon 72 polymorphism as a risk factor for cardiovascular disease in a Brazilian population.
    Smith MA; Silva MD; Cendoroglo MS; Ramos LR; Araujo LM; Labio RW; Burbano RR; Chen ES; Payão SL
    Braz J Med Biol Res; 2007 Nov; 40(11):1465-72. PubMed ID: 17934643
    [TBL] [Abstract][Full Text] [Related]  

  • 84. X-ray repair cross-complementing group 1 codon 399 polymorphism and lung cancer risk: an updated meta-analysis.
    Wang JY; Cai Y
    Tumour Biol; 2014 Jan; 35(1):411-8. PubMed ID: 23943371
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Assessment of the XPC (A2920C), XPF (T30028C), TP53 (Arg72Pro) and GSTP1 (Ile105Val) polymorphisms in the risk of cutaneous melanoma.
    Oliveira C; Rinck-Junior JA; Lourenço GJ; Moraes AM; Lima CS
    J Cancer Res Clin Oncol; 2013 Jul; 139(7):1199-206. PubMed ID: 23568549
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Arg399Gln XRCC1 Polymorphism and Risk of Squamous Cell Carcinoma of the Head and Neck in Jordanian Patients.
    Sobiahe A; Hijazi E; Al-Ameer HJ; Almasri Y; Jarrar Y; Zihlif M; Shomaf M; Al-Rawashdeh B
    Asian Pac J Cancer Prev; 2020 Mar; 21(3):663-665. PubMed ID: 32212791
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Impact of codon 72 Arg > Pro single nucleotide polymorphism in TP53 gene in the risk of kangri cancer: a case control study in Kashmir.
    Pandith AA; Khan NP; Rashid N; Azad N; Zaroo I; Hafiz A; Siddiqi MA
    Tumour Biol; 2012 Aug; 33(4):927-33. PubMed ID: 22249977
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Alterations in XRCC1 gene profile in pathogenesis of oral cavity cancer: A population-based study from Kamrup Urban District of Assam, India.
    Borkotoky R; Malakar B; Saikia AK; Mukherjee SN; Bose S
    Curr Probl Cancer; 2020 Feb; 44(1):100473. PubMed ID: 30954277
    [TBL] [Abstract][Full Text] [Related]  

  • 89. TP53 codon 72 polymorphism is associated with FGFR3 and RAS mutation in non-muscle-invasive bladder cancer.
    Kawahara T; Kojima T; Kandori S; Kurobe M; Yoshino T; Kimura T; Nagumo Y; Ishituka R; Mitsuzuka K; Narita S; Kobayashi T; Matsui Y; Ogawa O; Sugimoto M; Miyazaki J; Nishiyama H
    PLoS One; 2019; 14(8):e0220173. PubMed ID: 31369573
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Prognostic value of TP53 Pro47Ser and Arg72Pro single nucleotide polymorphisms and the susceptibility to gliomas in individuals from Southeast Brazil.
    Pinto GR; Yoshioka FK; Silva RL; Clara CA; Santos MJ; Almeida JR; Burbano RR; Rey JA; Casartelli C
    Genet Mol Res; 2008 Feb; 7(1):207-16. PubMed ID: 18393224
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A meta-analysis of TP53 codon 72 polymorphism and lung cancer risk: evidence from 15,857 subjects.
    Li Y; Qiu LX; Shen XK; Lv XJ; Qian XP; Song Y
    Lung Cancer; 2009 Oct; 66(1):15-21. PubMed ID: 19178978
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Lack of influence of TP53 Arg72Pro and 16bp duplication polymorphisms on risk of breast cancer in Iran.
    Gohari-Lasaki S; Gharesouran J; Ghojazadeh M; Montazeri V; Mohaddes Ardebili SM
    Asian Pac J Cancer Prev; 2015; 16(7):2971-4. PubMed ID: 25854391
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Relationships of TP53 codon 72 and HRAS1 polymorphisms with lung cancer risk in an ethnically diverse population.
    Pierce LM; Sivaraman L; Chang W; Lum A; Donlon T; Seifried A; Wilkens LR; Lau AF; Le Marchand L
    Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1199-204. PubMed ID: 11097227
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Chilean pilot study on the risk of lung cancer associated with codon 72 polymorphism in the gene of protein p53.
    Irarrázabal CE; Rojas C; Aracena R; Márquez C; Gil L
    Toxicol Lett; 2003 Sep; 144(1):69-76. PubMed ID: 12919725
    [TBL] [Abstract][Full Text] [Related]  

  • 95. TP53 codon 72 polymorphism and type 2 diabetes: a case-control study in South Indian population.
    Punja HK; Nanjappa DP; Babu N; Kalladka K; Shanti Priya Dias B; Chakraborty G; Rao SM; Chakraborty A
    Mol Biol Rep; 2021 Jun; 48(6):5093-5097. PubMed ID: 34181170
    [TBL] [Abstract][Full Text] [Related]  

  • 96. XRCC1 codon 399 mutant allele: a risk factor for recurrence of urothelial bladder carcinoma in patients on BCG immunotherapy.
    Mittal RD; Singh R; Manchanda PK; Ahirwar D; Gangwar R; Kesarwani P; Mandhani A
    Cancer Biol Ther; 2008 May; 7(5):645-50. PubMed ID: 18364571
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Polymorphisms of TP53 codon 72 with prostate carcinoma risk: a meta-analysis.
    Zhang J; Zhuo WL; Zheng Y; Zhang YS
    Med Oncol; 2010 Jun; 27(2):540-6. PubMed ID: 19499352
    [TBL] [Abstract][Full Text] [Related]  

  • 98. TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis.
    Matakidou A; Eisen T; Houlston RS
    Mutagenesis; 2003 Jul; 18(4):377-85. PubMed ID: 12840112
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The XRCC 1 DNA repair gene modifies the environmental risk of stomach cancer: a hospital-based matched case-control study.
    Putthanachote N; Promthet S; Hurst C; Suwanrungruang K; Chopjitt P; Wiangnon S; Chen SL; Yen AM; Chen TH
    BMC Cancer; 2017 Oct; 17(1):680. PubMed ID: 29020930
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Association of P53 codon 72 polymorphism and lung cancer in an ethnic Iranian population.
    Eydian Z; Asna'ashari AM; Behravan J; Sharifi-Rad J; Entezari Heravi R
    Cell Mol Biol (Noisy-le-grand); 2016 Aug; 62(9):34-8. PubMed ID: 27585259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.